C-Diff: Stopping the Spread

From my morning reading feed, here’s a slightly different take. We already know that Vancomycin and Fidoxamycin have show superior clinical results (i.e. better cure rate, less chance of relapse) than Metronidazole, which is why treatment guidelines have changed. And of course that’s important to us as individual patients. But according to this study, treating with Vancomycin or Fidoxamycin is also better for decreasing transmission because they decrease shedding of spores more quickly than Metronidazole. That’s important in hospitals and assisted living facilities especially. So, these treatment options are better for individual patients and better for the community. #research

Leave a comment

Filed under C-Diff

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s